rs4544

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000498.3(CYP11B2):​c.1016T>C​(p.Ile339Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0314 in 1,613,748 control chromosomes in the GnomAD database, including 6,525 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I339V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.12 ( 3327 hom., cov: 32)
Exomes 𝑓: 0.022 ( 3198 hom. )

Consequence

CYP11B2
NM_000498.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.599

Publications

30 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018127918).
BP6
Variant 8-142913390-A-G is Benign according to our data. Variant chr8-142913390-A-G is described in ClinVar as Benign. ClinVar VariationId is 362201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.388 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000498.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
NM_000498.3
MANE Select
c.1016T>Cp.Ile339Thr
missense
Exon 6 of 9NP_000489.3P19099

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
ENST00000323110.2
TSL:1 MANE Select
c.1016T>Cp.Ile339Thr
missense
Exon 6 of 9ENSP00000325822.2P19099
CYP11B2
ENST00000945895.1
c.1016T>Cp.Ile339Thr
missense
Exon 6 of 9ENSP00000615954.1
CYP11B2
ENST00000945896.1
c.1016T>Cp.Ile339Thr
missense
Exon 6 of 9ENSP00000615955.1

Frequencies

GnomAD3 genomes
AF:
0.121
AC:
18396
AN:
151976
Hom.:
3299
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.392
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0585
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.0221
Gnomad SAS
AF:
0.0614
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.00844
Gnomad OTH
AF:
0.101
GnomAD2 exomes
AF:
0.0455
AC:
11401
AN:
250774
AF XY:
0.0385
show subpopulations
Gnomad AFR exome
AF:
0.398
Gnomad AMR exome
AF:
0.0438
Gnomad ASJ exome
AF:
0.00646
Gnomad EAS exome
AF:
0.0215
Gnomad FIN exome
AF:
0.00434
Gnomad NFE exome
AF:
0.00969
Gnomad OTH exome
AF:
0.0319
GnomAD4 exome
AF:
0.0221
AC:
32258
AN:
1461654
Hom.:
3198
Cov.:
37
AF XY:
0.0216
AC XY:
15685
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.406
AC:
13606
AN:
33476
American (AMR)
AF:
0.0452
AC:
2021
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00723
AC:
189
AN:
26136
East Asian (EAS)
AF:
0.0126
AC:
499
AN:
39686
South Asian (SAS)
AF:
0.0490
AC:
4223
AN:
86254
European-Finnish (FIN)
AF:
0.00477
AC:
254
AN:
53232
Middle Eastern (MID)
AF:
0.0437
AC:
252
AN:
5768
European-Non Finnish (NFE)
AF:
0.00801
AC:
8906
AN:
1111986
Other (OTH)
AF:
0.0382
AC:
2308
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1761
3522
5283
7044
8805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.121
AC:
18474
AN:
152094
Hom.:
3327
Cov.:
32
AF XY:
0.118
AC XY:
8742
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.393
AC:
16287
AN:
41448
American (AMR)
AF:
0.0583
AC:
892
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3470
East Asian (EAS)
AF:
0.0221
AC:
114
AN:
5152
South Asian (SAS)
AF:
0.0614
AC:
296
AN:
4820
European-Finnish (FIN)
AF:
0.00518
AC:
55
AN:
10620
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.00843
AC:
573
AN:
67974
Other (OTH)
AF:
0.100
AC:
211
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
599
1198
1797
2396
2995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0435
Hom.:
3492
Bravo
AF:
0.136
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00804
AC:
31
ESP6500AA
AF:
0.378
AC:
1665
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.0524
AC:
6364
EpiCase
AF:
0.0111
EpiControl
AF:
0.0107

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Corticosterone 18-monooxygenase deficiency (1)
-
-
1
Corticosterone methyl oxidase type II deficiency (1)
-
-
1
Corticosterone methyloxidase type 2 deficiency (1)
-
-
1
Glucocorticoid-remediable aldosteronism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
18
DANN
Benign
0.87
DEOGEN2
Benign
0.081
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.89
FATHMM_MKL
Benign
0.0099
N
LIST_S2
Benign
0.062
T
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.55
N
PhyloP100
0.60
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
1.3
N
REVEL
Benign
0.089
Sift
Benign
0.12
T
Sift4G
Benign
0.44
T
Polyphen
0.0
B
Vest4
0.024
MPC
0.29
ClinPred
0.0013
T
GERP RS
3.7
Varity_R
0.18
gMVP
0.70
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4544; hg19: chr8-143994806; API